CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study

Improved Survival in Osteosarcoma Patients with Atypical Low Vascularization

(2014) Pierre Kunz et al.   ANNALS OF SURGICAL ONCOLOGY

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

(2014) C. Khanna et al.   CLINICAL CANCER RESEARCH

Recent advances in osteosarcoma

(2014) Sander M Botter et al.   CURRENT OPINION IN PHARMACOLOGY

Osteosarcoma Microenvironment: Whole-Slide Imaging and Optimized Antigen Detection Overcome Major Limitations in Immunohistochemical Quantification

(2014) Pierre Kunz et al.   PLoS One

Programmed Cell Death Ligand 1 Expression in Osteosarcoma

(2014) J. K. Shen et al.   Cancer Immunology Research

Prognostic Factors in Elderly Osteosarcoma Patients: A Multi-institutional Retrospective Study of 86 Cases

(2013) Shintaro Iwata et al.   ANNALS OF SURGICAL ONCOLOGY

Osteosarcoma treatment – Where do we stand? A state of the art review

(2013) Anja Luetke et al.   CANCER TREATMENT REVIEWS

Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response

(2013) Samantha L. Bailey-Bucktrout et al.   IMMUNITY

Shrinkage methods enhanced the accuracy of parameter estimation using Cox models with small number of events

(2013) I-Feng Lin et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis

(2013) Marnie Collins et al.   JOURNAL OF CLINICAL ONCOLOGY

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

(2013) Jérôme Galon et al.   JOURNAL OF PATHOLOGY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis

(2013) Ling Wang et al.   PLoS One

The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

(2013) Claudia C. Preston et al.   PLoS One

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

(2013) S. Spranger et al.   Science Translational Medicine

Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?

(2013) Giovanni Antonio Maria Povoleri et al.   Frontiers in Immunology

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

(2012) K. Oleinika et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cancer classification using the Immunoscore: a worldwide task force

(2012) Jérôme Galon et al.   Journal of Translational Medicine

Tumor Infiltrating CD8+ and Foxp3+ Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer

(2012) Anders Näsman et al.   PLoS One

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

(2012) Douglas G. Altman et al.   PLOS MEDICINE

Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

(2011) Bernhard Mlecnik et al.   JOURNAL OF CLINICAL ONCOLOGY

Intracerebral Human Regulatory T Cells: Analysis of CD4+CD25+FOXP3+ T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients

(2011) Benedikt Fritzsching et al.   PLoS One

Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

(2010) J. Smida et al.   CLINICAL CANCER RESEARCH

Prognostic markers in osteosarcoma

(2010) Sameer Bakhshi et al.   Expert Review of Anticancer Therapy

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

(2010) Kenneth F. Schulz et al.   PLOS MEDICINE

Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma

(2009) Hiroshi Urakawa et al.   CLINICAL & EXPERIMENTAL METASTASIS

Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor

(2009) Makoto Miyara et al.   IMMUNITY

Doxorubicin enhances CD4+ T-cell immune responses by inducing expression of CD40 ligand and 4-1BB

(2009) Jae Yeo Park et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Validation of Biomarker-Based Risk Prediction Models

(2008) J. M.G. Taylor et al.   CLINICAL CANCER RESEARCH